These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4231027)

  • 1. Coagulation, clot lysis, and thrombosis. I. Acid-labile inhibitor of fibrinolysis in rats fed thrombogenic diets.
    Sisson JA; Lee KT; Jadick PF; Thomas WA
    Exp Mol Pathol; 1968 Apr; 8(2):159-70. PubMed ID: 4231027
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis--a perspective.
    Kwaan HC
    Prog Cardiovasc Dis; 1979; 21(5):397-403. PubMed ID: 154125
    [No Abstract]   [Full Text] [Related]  

  • 3. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variation of plasminemia during experimental thrombolysis].
    Courbier R; Vairel E; Josserand JM; Bourgade P; Henry E
    Presse Med (1893); 1969 Oct; 77(41):1427-8. PubMed ID: 4242099
    [No Abstract]   [Full Text] [Related]  

  • 5. Urokinase-induced fibrin clot lysis and its inhibition by plasma.
    Carlin G
    Ups J Med Sci; 1980; 85(1):29-33. PubMed ID: 6446181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
    Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
    Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
    [No Abstract]   [Full Text] [Related]  

  • 10. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 12. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
    Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 15. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent progress in fibrinolysis.
    Mannucci PM; Minetti D; Mari D
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
    [No Abstract]   [Full Text] [Related]  

  • 19. FIBRINOLYSIS IN RELATION TO THROMBOSIS.
    FLUTE PT
    Ann R Coll Surg Engl; 1965 Apr; 36(4):225-34. PubMed ID: 14280974
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolysis in trauma patients: wide variability demonstrated by the Lysis Timer.
    Roullet S; Weinmann L; Labrouche S; Gisbert-Mora C; Biais M; Revel P; Freyburger G
    Scand J Clin Lab Invest; 2019; 79(1-2):136-142. PubMed ID: 30861350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.